NMDA receptor subtype differential affinity as a key enabler for precision neuropsychiatry

2026/05/10 by Aline Freyssin, Reina Benabou, Hanna Zoe Müller +4 · 1 voice
Medicine · Neuroscience · #Neuroscience and Neuropharmacology Research #Treatment of Major Depression #Tryptophan and brain disorders

paper · doi:10.1016/j.pnpbp.2026.111742

openalex publication_date 2026/05/10 · crossref created 2026/05/10 · openalex created_date 2026/05/11 · crossref issued 2026/06/01 · crossref published 2026/06/01 · crossref published-print 2026/06/01 · openalex updated_date 2026/06/19 · crossref deposited 2026/07/28 · crossref indexed 2026/07/28

Citations

• GluN2D-Containing N-methyl-d-Aspartate Receptors Mediate Synaptic Transmission in Hippocampal Interneurons and Regulate Interneuron Activity
• Fluoroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive Behavior
• Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels

Discussions

• Wirksame Therapien für neuropsychiatrische Erkrankungen sind eine Herausforderung. #NMI -Forschende haben analysiert, warum ein neuer Wirkstoffkandidat womöglich weniger #Nebenwirkungen hat. Zum aktue [bsky, 1 points, 0 comments]